Physician profile
William Butler
NPI 1699834762
$1,676.52
in general payments reported to CMS, 2019-2025
9 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $376 · 2020: $105 · 2022: $567 · 2023: $258 · 2024: $248 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $628.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopervision INC. | $400.40 | 2019-2025 | Myday Contact Lens |
| Sight Sciences, INC. | $312.97 | 2022-2023 | Tearcare System |
| Sun Pharmaceutical Industries INC. | $238.77 | 2022-2023 | Cequa |
| Shire North American Group INC | $232.92 | 2019 | |
| Abbvie INC. | $145.63 | 2022 | |
| Glaukos Corporation | $127.70 | 2023 | |
| Rxsight INC | $124.00 | 2024 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Visioneering Technologies, INC. | $69.60 | 2019 | |
| Alcon Vision LLC | $24.53 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Butler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.